Background: A greater intake of vegetables and fruits has been linked to a reduced incidence of colon cancer. Flavonoids are polyphenolic compounds which are broadly distributed in fruits and vegetables and display a remarkable spectrum of physiological activities, including anti-carcinogenic effects. The objective of this study was to determine the mechanisms by which kaempferol, a flavonol present in tea, apples, strawberries, and beans, inhibits the growth of HT-29 human colon cancer cells. Methods: To examine the effects of kaempferol on cell cycle progression in HT-29 cells, cells were treated with various concentrations (0-60 μmol/L) of kaempferol. Cell proliferation and DNA synthesis were evaluated by MTT assay and [
INTRODUCTION
Colon cancer is one of the principal causes of cancerrelated deaths in Western countries, 1 Epidemiological studies have shown that colorectal cancer risk decreases with higher intake of vegetables, fruits, and grains. 2, 3 Flavonoids are a class of more than 4,000 phenylbenzopyrones which occur in many edible plants, including vegetables and fruits, and are receiving considerable attention for their contribution to the anticarcinogenic properties associated with these foods. 4, 5 Previous studies have shown that several flavonoids exhibit potent anti-tumor activity against several rodent and human colon cancer cell lines. 6, 7 Kaempferol, a flavonol, is commonly found in many types of fruits and vegetables including beans, apples, broccoli, and strawberries, 8 and epidemiological studies have provided evidence that there is a negative correlation between kaempferol intake and cancer risk. 9 In the present study we examined whether kaempferol induces cell cycle arrest in HT-29 human colon cancer cells. The results of this study indicate that kaempferol inhibits the proliferation of HT-29 cells, and that the inhibition of both G1 and G2/M cell cycle progression is responsible, at least in part, for kaempferol-induced growth inhibition of HT-29 cells.
MATERIALS AND METHODS
Materials
We purchased reagents from the following suppliers: ka- were then incubated for a further 3 h in order to measure the incorporation into DNA as previously described. 
Fluorescence-activated cell sorting (FACS) analysis
Cells were serum-starved and treated with kaempferol as described above. To estimate cell cycle phase distribution, cells were separated by trypsin-EDTA, fixed in ethanol, treated with RNase, and the cellular DNA was then stained with propidium iodide, as previously described. 12 The percentage of cells in the G1, S and G2/M phases of the cell cycle were analyzed by flow cytometry (Becton Dickinson, Franklin Lake, NJ, USA).
Immunoprecipitation & Western blot analyses
Total cell lysates were prepared as previously described. 13 Total cell lysates (1 mg protein) were incubated with anti-CDK2, anti-CDK4, or Cdc2 antibody for 1 h, and were then immunoprecipitated by protein A-Sepharose beads as previously described. 12 The immunoprecipitates or total cell lysates (50 μg protein) were analyzed by Western blot analysis with their relevant antibodies, as previously described. 13 
In vitro kinase assay
We estimated CDK activity as previously described. 14 (Fig. 2B ).
Kaempferol inhibits the phosphorylation of Rb in HT-29 cells
We next examined the effect of kaempferol on the levels of proteins involved in the regulation of G1-S transition by
Western blot analyses. The cell cycle transition is regulated by CDKs, and CDKs activities are regulated by cyclins and CDK inhibitors. 15 As shown in Fig. 3A , kaempferol decreased the protein levels of CDK2 and CDK4, as well as those of cyclin D1, cyclin E, and cyclin A. However, p21
and p27 levels were not increased by kaempferol treatment (data not shown). Western blot analysis with an antibody specific to P-Rb revealed that kaempferol treatment reduced the levels of P-Rb. When the Western blots were probed using the total Rb antibody, kaempferol decreased the hyper-phosphorylated Rb levels and increased the hypo-phosphorylated Rb levels (Fig. 3A) . To detect CDK activity, CDK2 and CDK4 enzyme complexes were immunoprecipitated with CDK2 and CDK4 antibody, respectively, and the in vitro kinase assay was performed using histone H1 (HH1) or Rb as a substrate. The results showed that kaempferol decreased CDK2 and CDK4
activities within 30 min of 60 μmol/L kaempferol treatment (Fig. 3B) . These data indicate that kaempferol induced G1 phase arrest by inhibition of CDK2 and CDK4 activities.
Kaempferol inhibits Cdc2 activity in HT-29 cells
Western blot analysis revealed that the expression of (Fig. 4A) . However, Cdc2 activity, as estimated by immunopreciptation and in vitro kinase assay, was decreased 8 h after the addition of kaempferol (Fig. 4B) .
DISCUSSION
Over the past several decades, considerable attempts have been made to iderntify food components which inhibit, retard or reverse multi-stage carcinogenesis. 16 Flavonoids, commonly found in fruits and vegetables, display remarkable anti-carcinogenic properties. 5, 17 Kaempferol, a member of flavonoids, is abundantly present in beans, apples, broccoli, and strawberries, 8 and exhibits cancer preventive properties. 9 Epidemiological evidence indicates that a high intake of kaempferol is negatively correlated with risk of advanced colorectal adenoma recurrence. 18 Because previous studies by other investi- The present results suggest that kaempferol may be used as an agent for the prevention of colon cancer. However, kaempferol's efficacy against tumor development and promotion in vivo will depend chiefly upon its bioavailability to the various tissues, an area that is yet to be systematically researched. In German healthy female students the mean intake estimate (7-day period) of kaempferol was 4.7 mg/d and the mean plasma concentration was 10.7 nmol/L. 20 The concentrations used in the present in vitro cell culture experiments were 20-60 μmol/L, which are much higher than those found in human blood samples.
However, unabsorbed dietary kaempferol may be pre- Mammalian cell cycle is composed of 4 phases; G1, S, G2, and M phases, and dysregulation of cell cycle progression is one of the hallmarks of cancer. 21 In the present study kaempferol treatment induced G1 arrest within 6 h ( Fig. 2A) .
A wide variety of cell types respond to many growth factors by the activation of CDK4. Kinase activity of CDK4 requires the binding of the positive regulatory subunit, known as cyclin D1. 22 In the present experiment, kaempferol decreased the levels of CDK4 and cyclin D1 proteins within 6 h in a dose-dependent manner (Fig. 3A) . CDK4 activity was drastically decreased within 0.5 h after kaempferol treatment (Fig. 3B) . In addition to the inhibition of CDK4 activity, kaempferol decreased the levels of CDK2, cyclin A
and cyclin E proteins, leading to a decreased CDK2 activity.
These results clearly showed that kaempferol induces a reduction in the protein levels of CDKs and cyclins, thereby reducing the activity of these enzymes in HT-29 cells.
Members of the Rb protein are phosphorylated by CDKs, leading to the stimulation of gene expression necessary for G1-S cell cycle progression. 23 In the present experiment,
Western blot analysis of total cell lysates with P-Rb antibody revealed that kaempferol decreased P-Rb levels.
When the immunoblot was probed using total Rb antibody, two bands were detected with increased intensity of hypo-phosphorylated Rb being noted in cells treated with kaempferol (Fig. 3A) . Hypo-phosphorylated Rb tightly associates with a family of transcription activators the E2F proteins, and thereby represses transcription. 23 Together, these results suggest that a reduction in CDK activity leads to increased hypo-phosphorylated Rb (decreased phosphorylation of Rb) in cells treated with kaempferol. As a result, E2F cannot activate those genes necessary for the completion of the G1 to S phase transition.
In addition to the inhibition of the G1/S cell cycle transition, treatment of HT-29 cells with kaempferol for 12 h led to G2/M arrest ( Fig. 2A) .The G2/M checkpoint blocks cells from dividing when DNA is damaged, providing a chance for restoration and the prevention of the proliferation of damaged cells. 24 Inhibitors of the G2/M may be useful for the prevention and treatment of cancer. Cdc2 (or CDK-1) is activated by interaction with cyclin B1, and the activation of Cdc2 is required for G2/M transition. 
